Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis

被引:173
作者
Siddiqui, I. A. [1 ]
Malik, A. [1 ]
Adhami, V. M. [1 ]
Asim, M. [1 ]
Hafeez, B. B. [1 ]
Sarfaraz, S. [1 ]
Mukhtar, H. [1 ]
机构
[1] Univ Wisconsin, Med Sci Ctr B 25, Dept Dermatol, Madison, WI 53706 USA
关键词
EGCG; TRAIL; intrinsic pathway; extrinsic pathway; angiogenesis; metastasis;
D O I
10.1038/sj.onc.1210840
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL/Apo2L) is a promising candidate for cancer therapy, however, emergence of drug resistance limits its potential use. Here, we report for the first time that epigallocatechin-3-gallate (EGCG), the major polyphenolic constituent of green tea, sensitizes TRAIL-resistant LNCaP cells to TRAIL-mediated apoptosis through modulation of intrinsic and extrinsic apoptotic pathways. When combined with EGCG, Apo2L/TRAIL exhibited enhanced apoptotic activity in LNCaP cells characterized by three major molecular events. First, apoptosis induction was accompanied by the upregulation of poly (ADP-ribose) polymerase cleavage and modulation of pro-and antiapoptotic Bcl2 family of proteins. A synergistic inhibition of inhibitors of apoptosis with concomitant increase in caspase cleavage was observed. Second, pretreatment of cells with EGCG resulted in modulation of death-inducing signaling cascade complex involving DR4/TRAIL R1, Fas-associated death domain and FLICE-inhibitory protein proteins. Last, we observed a synergistic inhibition in the invasion and migration of LNCaP cells. This effect was observed to be mediated through inhibition in the protein expression of vascular endothelial growth factor, uPA and angiopoietin 1 and 2. Further, the activity and protein expression of MMP-2, -3 and -9 and upregulation of TIMP1 in cells treated with a combination of EGCG and TRAIL was observed. These data might have implications for developing new strategies aimed at eliminating prostate cancer cells resistant to TRAIL.
引用
收藏
页码:2055 / 2063
页数:9
相关论文
共 33 条
[1]   Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo [J].
Adhami, Vaqar Mustafa ;
Malik, Arshi ;
Zaman, Najia ;
Sarfaraz, Sami ;
Siddiqui, Imtiaz Ahmad ;
Syed, Deeba Nadeem ;
Afaq, Farrukh ;
Pasha, Farrukh Sierre ;
Saleem, Mohammad ;
Mukhtar, Hasan .
CLINICAL CANCER RESEARCH, 2007, 13 (05) :1611-1619
[2]   Oral consumption of green tea polyphenols inhibits insulin-like growth factor-i-induced signaling in an autochthonous mouse model of prostate cancer [J].
Adhami, VM ;
Siddiqui, IA ;
Ahmad, N ;
Gupta, S ;
Mukhtar, H .
CANCER RESEARCH, 2004, 64 (23) :8715-8722
[3]   Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: A preliminary report from a one-year proof-of-principle study [J].
Bettuzzi, S ;
Brausi, M ;
Rizzi, F ;
Castagnetti, G ;
Peracchia, G ;
Corti, A .
CANCER RESEARCH, 2006, 66 (02) :1234-1240
[4]   The green tea catechins, (-)-epigallocatechin-3-gallate (EGCG) and (-)-epicatechin-3-gallate (ECG), inhibit HGF/Met signaling in immortalized and tumorigenic breast epithelial cells [J].
Bigelow, RLH ;
Cardelli, JA .
ONCOGENE, 2006, 25 (13) :1922-1930
[5]   TRAIL inhibits angiogenesis stimulated by VEGF expression in human glioblastoma cells [J].
Cantarella, G. ;
Risuglia, N. ;
Dell'Eva, R. ;
Lempereur, L. ;
Albini, A. ;
Pennisi, G. ;
Scoto, G. M. ;
Noonan, D. N. ;
Bernardini, R. .
BRITISH JOURNAL OF CANCER, 2006, 94 (10) :1428-1435
[6]   Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer [J].
Chen, XF ;
Thakkar, H ;
Tyan, F ;
Gim, S ;
Robinson, H ;
Lee, C ;
Pandey, SK ;
Nwokorie, C ;
Onwudiwe, N ;
Srivastava, RK .
ONCOGENE, 2001, 20 (42) :6073-6083
[7]   Clinical significance of urokinase-type plasminogen activator receptor (uPAR) expression in cancer [J].
de Bock, CE ;
Wang, Y .
MEDICINAL RESEARCH REVIEWS, 2004, 24 (01) :13-39
[8]  
Deeb D, 2004, MOL CANCER THER, V3, P803
[9]   TRAIL signalling: Decisions between life and death [J].
Falschlehner, Christina ;
Emmerich, Christoph H. ;
Gerlach, Bjoern ;
Walczak, Henning .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2007, 39 (7-8) :1462-1475
[10]   The androgen receptor directly targets the cellular Fas/FasL-associated death domain protein-like inhibitory protein gene to promote the androgen-independent growth of prostate cancer cells [J].
Gao, S ;
Lee, P ;
Wang, H ;
Gerald, W ;
Adler, M ;
Zhang, LY ;
Wang, YF ;
Wang, ZX .
MOLECULAR ENDOCRINOLOGY, 2005, 19 (07) :1792-1802